Literature DB >> 1437493

Putative therapeutic applications of calmodulin antagonists.

R Mannhold1, H Timmerman.   

Abstract

Calmodulin is the most important intracellular receptor protein for the second messenger calcium. The calcium-calmodulin complex regulates a number of physiological processes. An increasing number of pharmaceutical products is reported to interfere with the calcium-calmodulin complex. Despite the fact that the precise mechanisms of action of these so-called calmodulin antagonists await further clarification, reports accumulate in the literature indicating a broadening spectrum of putative therapeutic applications of calmodulin antagonists. Some of these applications, such as in cell proliferation, hypertension, congestive heart failure, arrhythmia and gastro-intestinal disorders, are discussed in the present review.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1437493     DOI: 10.1007/bf01962532

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  21 in total

1.  Quantitative structure-activity relationships for calmodulin inhibitors.

Authors:  Q Liu; S Hirono; I Moriguchi
Journal:  Chem Pharm Bull (Tokyo)       Date:  1990-08       Impact factor: 1.645

2.  Inhibition of endothelium-dependent smooth muscle relaxation by calmodulin antagonists.

Authors:  G Weinheimer; H Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

3.  Antitumor effect of calmodulin antagonist against MH-134 hepatoma, Ehrlich ascites carcinoma and B-16 melanocarcinoma in mice.

Authors:  H Ito; H Hidaka
Journal:  Eur J Cancer Clin Oncol       Date:  1983-08

4.  Calcium ionophore (A23187)- and arachidonic acid-stimulated prostaglandin release from microvascular endothelial cells: effects of calcium antagonists and calmodulin inhibitors.

Authors:  M E Gerritsen; D M Nganele; A M Rodrigues
Journal:  J Pharmacol Exp Ther       Date:  1987-03       Impact factor: 4.030

5.  The role of calcium in the regulation of prostacyclin synthesis by porcine aortic endothelial cells.

Authors:  A R Whorton; C E Willis; R S Kent; S L Young
Journal:  Lipids       Date:  1984-01       Impact factor: 1.880

6.  Effects of metal cations and calmodulin antagonists on [3H] nitrendipine binding in smooth and cardiac muscle.

Authors:  E M Luchowski; F Yousif; D J Triggle; S C Maurer; J G Sarmiento; R A Janis
Journal:  J Pharmacol Exp Ther       Date:  1984-09       Impact factor: 4.030

7.  Role of calmodulin in neurotransmitter synthesis.

Authors:  H Fujisawa; T Yamauchi; H Nakata; S Okuno
Journal:  Fed Proc       Date:  1984-12

8.  Comparative antiarrhythmic and electrophysiological effects of drugs known to inhibit calmodulin (TFP, W7 and bepridil).

Authors:  E Barron; R J Marshall; M Martorana; E Winslow
Journal:  Br J Pharmacol       Date:  1986-11       Impact factor: 8.739

9.  Inhibition of calmodulin and protein kinase C by amiodarone and other class III antiarrhythmic agents.

Authors:  P J Silver; M J Connell; K M Dillon; W R Cumiskey; W A Volberg; A M Ezrin
Journal:  Cardiovasc Drugs Ther       Date:  1989-10       Impact factor: 3.727

10.  Cytotoxicity, calmodulin and DNA lesions in cells treated with streptozotocin.

Authors:  U Lönn; S Lönn
Journal:  Biochem Pharmacol       Date:  1988-09-15       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.